# Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma

> **NCT03015883** · NA · COMPLETED · sponsor: **Alpha Tau Medical LTD.** · enrollment: 28 (actual)

## Conditions studied

- Squamous Cell Carcinoma

## Interventions

- **RADIATION:** Diffusing Alpha Radiation Emitters Therapy (DaRT)

## Key facts

- **NCT ID:** NCT03015883
- **Lead sponsor:** Alpha Tau Medical LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-22
- **Primary completion:** 2019-06-01
- **Final completion:** 2019-06-25
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2021-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03015883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03015883, "Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03015883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*